Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Cancer Res. 2022 Sep 2;82(17):3187. doi: 10.1158/0008-5472.CAN-22-1308.
Cancer Res. 2022.
PMID: 36052496
No abstract available.